These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 9559626)

  • 41. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Online.
    Holmberg M; Kristo P; Chadwicks RB; Mecklin JP; Järvinen H; de la Chapelle A; Nyström-Lahti M; Peltomäki P
    Hum Mutat; 1998; 11(6):482. PubMed ID: 10200055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
    Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
    Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
    Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
    Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
    Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
    Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
    Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
    Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
    Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
    Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium.
    Millar AL; Pal T; Madlensky L; Sherman C; Temple L; Mitri A; Cheng H; Marcus V; Gallinger S; Redston M; Bapat B; Narod S
    Hum Mol Genet; 1999 May; 8(5):823-9. PubMed ID: 10196371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
    Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
    JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HNPCC: six new pathogenic mutations.
    Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W
    BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer.
    Capozzi E; Della Puppa L; Fornasarig M; Pedroni M; Boiocchi M; Viel A
    Eur J Cancer; 1999 Feb; 35(2):289-95. PubMed ID: 10448273
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer.
    Yuan Y; Han HJ; Zheng S; Park JG
    Dis Colon Rectum; 1998 Apr; 41(4):434-40. PubMed ID: 9559627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.
    Percesepe A; Borghi F; Menigatti M; Losi L; Foroni M; Di Gregorio C; Rossi G; Pedroni M; Sala E; Vaccina F; Roncucci L; Benatti P; Viel A; Genuardi M; Marra G; Kristo P; Peltomäki P; Ponz de Leon M
    J Clin Oncol; 2001 Oct; 19(19):3944-50. PubMed ID: 11579115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.
    Raedle J; Trojan J; Brieger A; Weber N; Schäfer D; Plotz G; Staib-Sebler E; Kriener S; Lorenz M; Zeuzem S
    Ann Intern Med; 2001 Oct; 135(8 Pt 1):566-76. PubMed ID: 11601928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1.
    Maruyama A; Miyamoto S; Saito T; Kondo H; Baba H; Tsukamoto N
    Cancer; 2001 Jun; 91(11):2056-64. PubMed ID: 11391585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of six novel MSH2 and MLH1 germline mutations in HNPCC.
    Krüger S; Plaschke J; Jeske B; Görgens H; Pistorius SR; Bier A; Kreuz FR; Theissig F; Aust DE; Saeger HD; Schackert HK
    Hum Mutat; 2003 Apr; 21(4):445-6. PubMed ID: 12655562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients.
    Paraf F; Gilquin M; Longy M; Gilbert B; Gorry P; Petit B; Labrousse F
    Histopathology; 2001 Sep; 39(3):250-8. PubMed ID: 11532035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
    Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
    Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of experimental conditions for RNA-based sequencing of MLH1 and MSH2 genes.
    Jakubowska A; Górski B; Kurzawski G; Debniak T; Hadaczek P; Cybulski C; Kladny J; Oszurek O; Scott RJ; Lubinski J
    Hum Mutat; 2001; 17(1):52-60. PubMed ID: 11139242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.